论文部分内容阅读
辉瑞“求婚”阿斯利康终遭拒绝2013年年底,市场中传出消息,美国制药巨头辉瑞正在和英国制药公司阿斯利康洽谈收购事项,收购金额可能高达1000亿美元。从市值排名来看,辉瑞目前坐拥近2000亿美元的庞大市值,位居全球第四位,而阿斯利康超过800亿美元的市值,也仅能勉强挤进市值前十。但如果辉瑞千亿美元收购阿斯利康成功,将打造行业中另一个全新的巨型企业,行业座次将
Pfizer “proposal” AstraZeneca end of rejection At the end of 2013, the market came the news that the US pharmaceutical giant Pfizer is negotiating with the British pharmaceutical company AstraZeneca acquisition, the amount of the acquisition may be as high as 100 billion US dollars. In terms of market value, Pfizer is currently the fourth largest in the world with a market capitalization of nearly 200 billion U.S. dollars, while AstraZeneca ’s market capitalization of more than 80 billion U.S. dollars can barely squeeze into the top 10 market cap. But if Pfizer’s $ 100 billion takeover of AstraZeneca is successful, it will create another brand new giant in the industry that will